Merit Medical Systems, Inc. (NASDAQ:MMSI) Receives $100.30 Average Target Price from Analysts

Merit Medical Systems, Inc. (NASDAQ:MMSI) has received a consensus recommendation of “Moderate Buy” from the twelve ratings firms that are currently covering the firm, Marketbeat Ratings reports. Four analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $100.00.

A number of equities analysts have recently issued reports on MMSI shares. Weiss Ratings raised Merit Medical Systems from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, August 3rd. Raymond James Financial restated an “outperform” rating and issued a $100.00 price target on shares of Merit Medical Systems in a research note on Friday, July 31st. Bank of America upped their price objective on Merit Medical Systems from $92.00 to $97.00 and gave the stock a “neutral” rating in a report on Thursday. JPMorgan Chase & Co. increased their price objective on Merit Medical Systems from $77.00 to $95.00 and gave the stock an “overweight” rating in a research report on Friday, July 31st. Finally, BTIG Research reissued a “buy” rating and issued a $105.00 target price on shares of Merit Medical Systems in a report on Tuesday.

Institutional Trading of Merit Medical Systems

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Kilter Group LLC purchased a new position in Merit Medical Systems in the second quarter valued at about $25,000. Los Angeles Capital Management LLC acquired a new stake in shares of Merit Medical Systems during the 4th quarter valued at approximately $25,000. Maseco LLP purchased a new stake in shares of Merit Medical Systems during the 4th quarter worth approximately $26,000. Torren Management LLC purchased a new stake in shares of Merit Medical Systems during the 4th quarter worth approximately $38,000. Finally, Covestor Ltd grew its holdings in shares of Merit Medical Systems by 252.6% in the 4th quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier’s stock worth $41,000 after acquiring an additional 336 shares during the period. Institutional investors and hedge funds own 99.66% of the company’s stock.

Merit Medical Systems Price Performance

Shares of NASDAQ MMSI opened at $90.76 on Friday. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.20 and a quick ratio of 2.79. The stock has a fifty day moving average price of $75.05 and a 200 day moving average price of $72.25. Merit Medical Systems has a 1-year low of $59.74 and a 1-year high of $94.75. The company has a market cap of $5.42 billion, a PE ratio of 37.50, a P/E/G ratio of 2.28 and a beta of 0.49.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings data on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.23. The company had revenue of $418.84 million for the quarter, compared to analysts’ expectations of $405.25 million. Merit Medical Systems had a net margin of 9.22% and a return on equity of 13.75%. Merit Medical Systems’s revenue was up 9.5% compared to the same quarter last year. During the same period in the previous year, the company posted $1.01 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. Sell-side analysts forecast that Merit Medical Systems will post 3.81 EPS for the current year.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.